AccessClosure announces distribution agreement for the FLASH Ostial System

Published on:

AccessClosure, Inc., the market leader in extravascular closure devices, announced today an exclusive agreement with Ostial Corporation to distribute the Flash Ostial System Dual Balloon Angioplasty Catheter in the United States. The Flash Ostial System is designed to help overcome the challenges of aorto-ostial stenting and compliments the Mynx® Product Family of Vascular Closure Devices to expand AccessClosure’s portfolio.

“AccessClosure is well-positioned to add relevant and useful products to our portfolio due to the strong relationships of our sales team with interventional cardiologists, vascular surgeons, and interventional radiologists through the sale of Mynx,” said Gregory D. Casciaro, President and CEO of AccessClosure. “As a customer-focused company, we strive to provide innovative technologies such as Mynx and Flash for superb clinical outcomes. Including the Flash Ostial System in our portfolio allows AccessClosure to increase our level of service and education to healthcare providers.”

Ostial lesions are a challenging area for treatment. According to Richard Kovach, M.D., Chair, Interventional Cardiology and Director, Cardiac Catheterization Laboratory at Deborah Heart and Lung Center, in Browns Mills, NJ, “The dual balloon design of the Flash Ostial System is an exciting treatment option for ostial disease.Flash conforms to the ostium to enable excellent stent apposition, which is important for coverage of the disease and for preserving reaccess to the treated vessel.” Dr. Kovach has been using the Flash Ostial System in his practice for the past year.

“AccessClosure is the ideal partner to distribute the Flash device,” said Yi Yang, Chief Operating Officer of Ostial Corporation. “Their sales team understands the importance of bringing innovative products to market that offer a clinical benefit.”

AccessClosure will showcase its growing portfolio of devices at booth 314 at the Vascular Interventional Advances 2013 (VIVA) this week in Las Vegas, NV, beginning Tuesday when the exhibit hall opens at the Wynn Hotel.

Related Content

IVUS-guided PCI reduces risks in patients with diabetes
LAAC with Watchman FLX reduces bleeding risks after AFib ablation
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Shockwave Medical’s IVL technology delivers more positive outcomes for PAD patients
Standing desks fail to lower blood pressure or minimize heart risks—they may even do damage
IVL vs. RA for chronic total occlusion PCI: Key data cardiologists should know

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."